Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Myriad Genetics: How Low Can It Go?
Barron's
Monday, December 30, 2013 - 11:37am
tags:
Myriad Genetics, breast cancer, diagnostics
The Billion-Dollar Biotech Club: Speculation Trumped Risk
TheStreet.com
Monday, December 30, 2013 - 11:35am
tags:
biotech
FDA starts review of Cubist Pharma antibiotic
Yahoo/AP
Monday, December 30, 2013 - 11:33am
tags:
FDA, antibiotics, Cubist Pharmaceuticals, tedizolid
Dendreon: A Cautionary Tale For Biotech Investors
Wall St Cheat Sheet
Monday, December 30, 2013 - 11:32am
tags:
Dendreon, Provenge
Isis Pharmaceuticals, Inc. (ISIS): Strong Industry, Solid Earnings Estimates Revisions
Yahoo/Zacks.com
Monday, December 30, 2013 - 11:17am
tags:
Isis Pharmaceuticals
Sanofi MS Drug Lemtrada Fails to Win Backing of U.S. FDA
Bloomberg
Monday, December 30, 2013 - 11:16am
tags:
Sanofi, Lemtrada, FDA, MS, multiple sclerosis
Acceleron, Celgene Vs. Amgen In The Anemia Drug Race
Seeking Alpha
Monday, December 30, 2013 - 11:15am
tags:
Amgen, Acceleron, Celgene, anemia, sotatercept, ACE-536
Amarin: 3 Things Shareholders Should Demand In 2014
Seeking Alpha
Monday, December 30, 2013 - 11:12am
tags:
Amarin, Vascepa
Why Merck Is Planning to Change Its Research Strategy
Wall St Cheat Sheet
Monday, December 30, 2013 - 10:17am
tags:
Merck, R&D
2014 Looking Like A Big Year For Nektar
Seeking Alpha
Monday, December 30, 2013 - 10:16am
tags:
Nektar, NKTR-118, NKTR-102
The Best- And Worst-Performing Biotech Stocks, Dec. 19 to Dec. 26
Forbes
Monday, December 30, 2013 - 10:15am
tags:
biotech, Inovio, United Therapeutics, Synergy Pharmaceuticals
Johnson & Johnson: Great Product Portfolio But Not Cheap
Seeking Alpha
Monday, December 30, 2013 - 10:12am
tags:
JNJ
ANI Pharma buys generic drugs from Teva
Globes, Israel
Sunday, December 29, 2013 - 9:52am
tags:
ANI Pharmaceuticals, Teva, generics
Firm to seek 1st approval for stem cell-based medicine in Japan
The Japan News
Sunday, December 29, 2013 - 9:51am
tags:
stem cells, JCR Pharmaceutical, graft vs host disease
Abbott Labs settles with U.S. over kickback claims
Reuters
Saturday, December 28, 2013 - 10:10am
tags:
Abbott Laboratories
Teva sells 31 generic drugs for $12.5M, and a cut of future profits
bizjournals.com
Saturday, December 28, 2013 - 9:55am
tags:
Teva
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
Friday, December 27, 2013 - 1:08pm
tags:
cancer, Roche, Infinity Pharmaceuticals, Inovio, Immunogen, Gilead Sciences, immunotherapy, antibody-drug conjugate
Weighing Out The Seattle Genetics Barbell
Seeking Alpha
Friday, December 27, 2013 - 1:03pm
tags:
Seattle Genetics, antibody-drug conjugate, Adcetris
The Race To Develop A Brain Cancer Treatment Takes An Interesting Turn
Forbes
Friday, December 27, 2013 - 1:01pm
tags:
brain cancer, glioblastoma multiforme, ImmunoCellular Therapeutics, Northwest Biotherapeutics, CytRx, Celldex Therapeutics, aldoxorubicin, DCVax
Roche: Some Companies Rebuild, This One Reloads
Motley Fool
Friday, December 27, 2013 - 12:18pm
tags:
Roche

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.